Higher BCG‐induced trained immunity prevalence predicts protection from COVID‐19: Implications for ongoing BCG trials
Singh S, Kishore D, Singh R, Pathak C, Ranjan K. Higher BCG‐induced trained immunity prevalence predicts protection from COVID‐19: Implications for ongoing BCG trials. Clinical And Translational Discovery 2022, 2: e60. PMID: 35938058, PMCID: PMC9347530, DOI: 10.1002/ctd2.60.Peer-Reviewed Original ResearchVaccination coverageLatent tuberculosis infection prevalenceTuberculosis infection prevalenceBCG vaccination coveragePotential protective benefitsCOVID-19COVID-19 incidenceBCG trialVaccination wanesBCG vaccinationBCG coverageBacillus CalmetteSmall study groupCOVID-19 casesStudy groupProtective effectProtective benefitsCOVID-19 impactProtective variablesPrevalenceInfection prevalenceCertain populationsMultiple attemptsTI estimatesTrials